Linking the Cardiac Nervous System to Atrial Fibrillation in Pulmonary Arterial Hypertension

P ulmonary arterial hypertension (PAH) is a rare, debilitat-ing disease characterized by an occlusive pulmonary vas-culopathy, resulting in elevated pulmonary vascular resistance and subsequently death from right ventricular (RV) failure. 1 Current therapeutic options in PAH are limited to pulmonary vasodilator therapy, which have improved clinical outcomes… CONTINUE READING